Precision Therapeutics Across Cancer, Immunology, and Pain

Targeted protein degradation, next-generation antibody discovery, and spatial multiomics are reshaping therapeutic strategies across oncology, immunology, and neurology. Recent innovations include platelet-sparing degraders of BCL-XL for cancer treatment, rare antibody recovery platforms for challenging antigens, in situ sequencing for immune repertoire mapping, and senolytic PROTACs that target pain-associated neurons. Together, these approaches exemplify how mechanistic precision and synergistic platforms can accelerate therapeutic breakthroughs.